Posted inTechnology News
AstraZeneca COVID-19 vaccine shows 74% efficacy in large US trial
AstraZeneca’s COVID-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company’s US…